Prescription drug · UNAPPROVED DRUG OTHER
Sodium Sulfacetamide, Sulfur NDC 24470-953
Sulfacetamide sodium 100 mg/g; Sulfur 50 mg/g · Liquid · Topical · Cintex Services, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24470-953-06 | 24470095306 | 170.3 g in 1 BOTTLE (24470-953-06)Marketed from Apr 23, 2026 | |
| 24470-953-12 | 24470095312 | 340.2 g in 1 BOTTLE (24470-953-12)Marketed from Apr 23, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium Sulfacetamide, Sulfur
- Generic name (nonproprietary)
- sodium sulfacetamide, sulfur
- Active ingredients
- Sulfacetamide sodium — 100 mg/gSulfur — 50 mg/g
- Dosage form
- Liquid
- Route
- Topical
- Labeler
- Cintex Services, LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonamides (Chemical structure)
- Identifiers
- Product ID 24470-953_502578d3-0992-910f-e063-6394a90a4243SPL ID 502578d3-0992-910f-e063-6394a90a4243SPL set ID 50257047-1dc4-854d-e063-6394a90a5020RxCUI 999613UNII 4NRT660KJQ, 70FD1KFU70UPC 0324470953124, 0324470953063
- Pharmacologic class
- Sulfonamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424470095306followed by a unit qualifier and the quantityPackage 24470-0953-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS: This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Excerpt only. Read the full label for complete information.